세계의 특수 제네릭 주사제 시장 규모 : 종류별(의약품, 생물제제), 용도별(종양, 순환기, 감염증, 중추신경계, 자가면역질환, 기타), 지역별 예측(2022-2028년)
Global Specialty Injectable Generics Market Size study, by Type (Drugs, Biologics), by Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others) and Regional Forecasts 2022-2028
세계의 특수 제네릭 주사제 시장 규모는 기존 의약품에 비해 가격이 낮고, 기한 만료되는 특허 수가 증가하고 있는 점, 신제품 발매, 질병 유행이 증가 경향에 있는 점 등에 의해 촉진되고 있습니다.
한편, 생물제제나 제네릭 주사제 제조는 고가이고 어려운 작업이기 때문에, 예측기간의 시장 성장을 저해할 가능성이 있습니다.
세계의 특수 제네릭 주사제(Specialty Injectable Generics) 시장을 조사했으며, 시장 개요, 시장 분석, 종류·용도·지역별 분석 및 경쟁 상황 등의 정보를 제공합니다.
Global Specialty Injectable Generics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Specialty Injectable Generics are drug therapies used for the treatment of chronic conditions that need injection, infusion, or inhalation and are sold as generics.. It includes biologics used in the treatment of a variety of drugs and has the same active ingredients as branded versions, although the inactive contents of the medications can vary. Specialty Injectable Generics are less expensive as compared to traditional drugs and growing number of patents set to expire have led to the adoption of Specialty Injectable Generics across the forecast period. For Instance: as per Statista in 2021, the global specialty generics market was valued at roughly 45 billion dollars in 2018, and it is predicted to grow to nearly 90 billion dollars by 2024. Due to patent expiration, the industry is anticipated to lose 19 billion dollars in prescription medicine sales worldwide by 2022. Following the expiration of a patent, other businesses are permitted to produce less expensive generic versions of the original branded drug. Also, as the key market participants are launching new products and illness prevalence is on the rise are likely to increase the market growth during the forecast period. However, manufacturing biologics and generic injectable is an expensive and difficult operation that may impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Specialty Injectable Generics Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of patents set to expire. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as key market participants launching new products and rising illness prevalence would create lucrative growth prospects for the Specialty Injectable Generics Market across Asia-Pacific region.
Major Market players included in this report are:
Dr. Reddy's Laboratories Ltd
Hikma Pharmaceuticals PLC
Sun Pharmaceutical Industries Ltd.
The objective of the study is to define Market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the Market. Additionally, the report shall also incorporate available opportunities in micro Markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the Market are explained below:
Central Nervous Systems
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Specialty Injectable Generics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers